Esophagogastroduodenoscopy
Esophagogastroduodenoscopy is a medical procedure with 31 clinical trials. Currently 9 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 13 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
3
Mid Stage
4
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
13 of 13 finished
0.0%
0 ended early
9
trials recruiting
31
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Obeticholic Acid for Prevention in Barrett's Esophagus
Clinical Trials (31)
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma
Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Obeticholic Acid for Prevention in Barrett's Esophagus
Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer
Trans-nasal Endoscopy for Bariatric Patients
Wired Magnetically Assisted Capsule Endoscopy and Esophageal Varices
GCC Agonist Signal in the Small Intestine
Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
Impact of a One-Week Discontinuation of Semaglutide on Gastric Retention and Endoscopic Mucosal Visibility Scores
24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)
GLP-1 Receptor Agonist Use and Incidence of Retained Gastric Food on Endoscopy
Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
Evaluation of Antral Biopsies Obtained in Normal Esophagogastroduodenoscopy
Correlation Between Endoscopic Findings And Helicobacter Pylori Infection In Chronic Kidney Disease Patients
Efficacy and Safety APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE-2)
Patient Acceptance and Preference Among Screening Modalities for Detection of Barrett's Esophagus
Efficacy of EsoGuard Assay on Esophageal Surface Cells Collected With EsoCheck vs EGD for the Diagnosis of BE or EAC
Microbiome/Peptidome-based Model for Non-invasive Detection of High-risk Gastroesophageal Varices in Compensated Cirrhosis (CHESS1901/APPHA1901)
Drug Details
- Intervention Type
- PROCEDURE
- Total Trials
- 31